Drug Recall: Sandoz Aprepitant Caps, Lidocaine/Prilocaine Cream

Click to enlarge

US/Washington: Sandoz Inc., a Princeton, New Jersey establishment, recalls an estimated 156,750 Aprepitant Capsules and Lidocaine/Prilocaine Cream from the American marketplace due to failure to meet US child resistant closure requirements under the US Poison Prevention Packaging Act and consequential risks of child poisoning, ingestion and GI tract laceration damage, all serious health and safety hazards.

CPSC: https://bit.ly/423xRw3

Direct link: https://www.cpsc.gov/Recalls/2023/Sandoz-Recalls-Aprepitant-Capsules-and-Lidocaine-and-Prilocaine-Cream-Prescription-Drugs-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves Aprepitant Capsules and Lidocaine and Prilocaine Cream products marketed, sold and delivered in the United States, as follows: